NCT06902038View on ClinicalTrials.gov

Clinical Research on the Use of Immune Checkpoint Inhibitors Combined With Chidamide for the Functional Cure of AIDS

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 22, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 31, 2027

Conditions

HIV-1 Infection

Interventions

DRUG

PD-1 inhibitor

100mg of sindilizumab, was dissolved into 50ml of normal saline q3w ×2

DRUG

Sidarbenamide

Sidarbenamide 10mg biw orally for 2 weeks

DRUG

Saline (NaCl 0,9 %) (placebo)

Saline 50ml Q3W ×2

All Listed Sponsors

lead

Jun Chen, MD

OTHER_GOV

NCT06902038 - Clinical Research on the Use of Immune Checkpoint Inhibitors Combined With Chidamide for the Functional Cure of AIDS | Biotech Hunter | Biotech Hunter